 MELVILLE, N.Y., March 22, 2021 GLOBE NEWSWIRE -- BioRestorative Therapies, Inc. the Company OTC: BRTX, a life sciences company focused on stem cell-based therapies, today announced that the United States Patent Office and several International agencies have issued notices of allowance for three separate patent applications related to the Companys metabolic ThermoStem Program. 